Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -80.65% is 33% below its 5-year average of -60.47%, near the low end of its 5-year range (-97.53%–-20.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.92% below its 12-month average of -78.37%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -80.65%.
RETURN ON INVESTED CAPITAL (ROIC)
-80.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-78.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-69.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-60.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-92.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.92%
CURRENT VS 3Y AVG
-15.68%
CURRENT VS 5Y AVG
-33.37%
CURRENT VS 10Y AVG
+12.60%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 723 covered companies
CURRENT VS SECTOR MEDIAN
-140.75%
vs the sector median at left
enVVeno Medical Corporation
Market Cap
$5.60M
Return on Invested Capital (ROIC)
-80.65%
TTM Avg
-78.37%
3Y Avg
-69.72%
5Y Avg
-60.47%
Market Cap
$5.63M
Return on Invested Capital (ROIC)
-94.08%
TTM Avg
-1223.16%
3Y Avg
-731.00%
5Y Avg
-532.24%
Market Cap
$5.77M
Return on Invested Capital (ROIC)
-84.15%
TTM Avg
-84.15%
3Y Avg
-84.15%
5Y Avg
-84.15%
Market Cap
$5.80M
Return on Invested Capital (ROIC)
-122.15%
TTM Avg
-90.24%
3Y Avg
-109.34%
5Y Avg
-347.01%
Market Cap
$5.91M
Return on Invested Capital (ROIC)
-0.32%
TTM Avg
-32.77%
3Y Avg
-50.72%
5Y Avg
-41.90%
Market Cap
$5.27M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-259.96%
3Y Avg
-220.56%
5Y Avg
-170.22%
Market Cap
$5.25M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$5.24M
Return on Invested Capital (ROIC)
-160.81%
TTM Avg
-121.99%
3Y Avg
-86.44%
5Y Avg
-69.30%
Market Cap
$5.21M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-67.32%
3Y Avg
-73.33%
5Y Avg
-73.33%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.60M | -80.65% | -78.37% | -69.72% | -60.47% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | -94.08% | -1223.16% | -731.00% | -532.24% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | -84.15% | -84.15% | -84.15% | -84.15% |
| Lucyd, Inc (LUCY)vs › | $5.80M | -122.15% | -90.24% | -109.34% | -347.01% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.91M | -0.32% | -32.77% | -50.72% | -41.90% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | -179.58% | -259.96% | -220.56% | -170.22% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.25M | -27.41% | -21.46% | -17.98% | -12.44% |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | -160.81% | -121.99% | -86.44% | -69.30% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | N/A | -67.32% | -73.33% | -73.33% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | -156.69% | -654.50% | -599.09% | -420.09% |
ROIC
-80.7%
ROE
-76.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -80.65% |
| 2026-03-31 | -82.16% |
| 2025-12-31 | -76.16% |
| 2025-09-30 | -78.74% |
| 2025-06-30 | -74.11% |
| 2025-03-31 | -59.81% |
| 2024-12-31 | -55.12% |
| 2024-09-30 | -48.60% |
| 2024-06-30 | -57.47% |
| 2024-03-31 | -55.24% |
| 2023-12-31 | -53.40% |
| 2023-09-30 | -97.53% |
| 2023-06-30 | -87.35% |
| 2023-03-31 | -74.46% |
| 2022-12-31 | -62.13% |
| 2022-09-30 | -62.20% |
| 2022-06-30 | -49.92% |
| 2022-03-31 | -36.67% |
| 2021-12-31 | -30.10% |
| 2021-09-30 | -20.77% |
| 2021-06-30 | -27.32% |
| 2021-03-31 | -23.99% |
| 2020-12-31 | -119.19% |
| 2020-09-30 | -122.92% |
| 2020-06-30 | -603.72% |
| 2020-03-31 | -1356.71% |
| 2019-12-31 | -454.88% |
| 2019-09-30 | -192.07% |
| 2019-06-30 | -127.16% |
| 2019-03-31 | -218.68% |
| 2018-12-31 | -385.71% |
| 2018-09-30 | -225.40% |
| 2018-06-30 | -180.22% |
| 2016-12-31 | -1195.04% |
| 2016-09-30 | -288.85% |
